Physician profile
Dean S Traiger
NPI 1679554992
$4,126.09
in general payments reported to CMS, 2019-2025
25 companies · $524 in 2025
The $524 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $549 · 2020: $119 · 2021: $143 · 2022: $641 · 2023: $1,064 · 2024: $1,086 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,673.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $938.33 | 2021-2025 | Vraylar, Qulipta, Synthroid |
| Glaxosmithkline, LLC. | $465.83 | 2019-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $456.70 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $305.38 | 2020-2025 | Mounjaro, Jardiance, Emgality |
| Merck Sharp & Dohme LLC | $293.22 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Astrazeneca Pharmaceuticals LP | $237.75 | 2019-2024 | Airsupra, Fasenra |
| Pfizer INC. | $225.33 | 2020-2025 | |
| Amgen INC. | $170.02 | 2019-2025 | Evenity, Prolia, Repatha |
| Janssen Pharmaceuticals, INC | $159.22 | 2019-2024 | Xarelto |
| Dexcom, INC. | $127.20 | 2022-2024 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $122.18 | 2022 | |
| Amarin Pharma, INC. | $105.94 | 2019-2022 | |
| Radius Health, INC. | $95.85 | 2019 | |
| Novartis Pharmaceuticals Corporation | $66.42 | 2022-2024 | |
| Astellas Pharma US INC | $64.63 | 2023-2025 | Veozah |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $63.17 | 2023 | Urolift |
| Exact Sciences Corporation | $61.73 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $42.60 | 2023 | Freestyle Libre 2 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.95 | 2020 | |
| Axsome Therapeutics, INC. | $19.72 | 2025 | Auvelity |
| Boston Scientific Corporation | $19.69 | 2025 | Watchman Flx |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.47 | 2025 | Caplyta |
| E.R. Squibb & Sons, L.L.C. | $13.97 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.43 | 2019 | |
| Almatica Pharma LLC | $12.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Traiger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.